GB9407386D0
(en)
|
1994-04-14 |
1994-06-08 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US20030109503A1
(en)
*
|
1995-06-06 |
2003-06-12 |
Smithkline Beecham P.L.C. |
Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
|
BR9610396A
(pt)
|
1995-09-07 |
1999-07-06 |
Smithkline Beecham Corp |
Formulação farmacêutica
|
AT407701B
(de)
*
|
1996-08-12 |
2001-05-25 |
Biochemie Gmbh |
Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
|
TWI225402B
(en)
|
1996-03-13 |
2004-12-21 |
Biochemie Gmbh |
Auxiliary-free agglomerates
|
AT407214B
(de)
*
|
1996-03-13 |
2001-01-25 |
Biochemie Gmbh |
Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
|
US20030124187A1
(en)
*
|
1997-02-14 |
2003-07-03 |
Smithkline Beecham Laboratoires Pharmaceutiques, |
Pharmaceutical formulations comprising amoxycillin and clavulanate
|
US7179486B1
(en)
*
|
1997-04-01 |
2007-02-20 |
Nostrum Pharmaceuticals, Inc. |
Process for preparing sustained release tablets
|
KR100502478B1
(ko)
*
|
1997-06-13 |
2005-12-02 |
동아제약주식회사 |
클라불란산과베타락탐계항생물질을포함하는세균감염증치료제용약학적조성물
|
AUPP437698A0
(en)
|
1998-06-30 |
1998-07-23 |
Baumgart, Karl |
Methods for treatment of coronary, carotid and other vascular disease
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
GB2365337A
(en)
*
|
1999-04-13 |
2002-02-20 |
Beecham Pharma |
Amoxycillin and potassium clavulanate high dosage regimen
|
US6294199B1
(en)
*
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
ATE242629T1
(de)
*
|
1999-04-13 |
2003-06-15 |
Beecham Pharm Pte Ltd |
Neue behandlungsmethode unter verwendung einer hochdosierten form von amoxycillin und kaliumclavulanat
|
US7250176B1
(en)
*
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
US6991807B2
(en)
*
|
2000-02-24 |
2006-01-31 |
Advancis Pharmaceutical, Corp. |
Antibiotic composition
|
US6669948B2
(en)
|
2000-02-24 |
2003-12-30 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6663890B2
(en)
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Metronidazole antibiotic product, use and formulation thereof
|
US6667057B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Levofloxacin antibiotic product, use and formulation thereof
|
US6638532B2
(en)
|
2000-02-24 |
2003-10-28 |
Advancis Pharmaceutical Corp. |
Tetracycline—doxycycline antibiotic composition
|
US6632453B2
(en)
|
2000-02-24 |
2003-10-14 |
Advancis Pharmaceutical Corp. |
Ciprofoxacin-metronidazole antibiotic composition
|
US6610328B2
(en)
|
2000-02-24 |
2003-08-26 |
Advancis Pharmaceutical Corp. |
Amoxicillin-clarithromycin antibiotic composition
|
US6667042B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Fluroquinilone antibiotic product, use and formulation thereof
|
US6663891B2
(en)
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Erythromyacin antibiotic product, use and formulation thereof
|
US6627222B2
(en)
|
2000-02-24 |
2003-09-30 |
Advancis Pharmaceutical Corp. |
Amoxicillin-dicloxacillin antibiotic composition
|
JP2003523372A
(ja)
|
2000-02-24 |
2003-08-05 |
アドバンシス ファーマシューティカル コーポレイション |
抗生物質及び抗真菌剤組成物
|
US6623758B2
(en)
|
2000-02-24 |
2003-09-23 |
Advancis Pharmaceutical Corp. |
Cephalosporin-metronidazole antibiotic composition
|
US6730320B2
(en)
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
JP2003531115A
(ja)
*
|
2000-02-24 |
2003-10-21 |
アドバンシス ファーマシューティカル コーポレイション |
インヒビターを有する抗生物質組成物
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US7025989B2
(en)
*
|
2000-02-24 |
2006-04-11 |
Advancis Pharmaceutical Corp. |
Multiple-delayed released antibiotic product, use and formulation thereof
|
US6924253B2
(en)
*
|
2000-04-07 |
2005-08-02 |
Bentley J. Palmer |
Scale removal
|
US6761895B2
(en)
*
|
2000-04-17 |
2004-07-13 |
Yamanouchi Pharmaceutical Co., Ltd. |
Drug delivery system for averting pharmacokinetic drug interaction and method thereof
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US7838032B2
(en)
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US8012504B2
(en)
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US7985420B2
(en)
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
AU2001279284A1
(en)
*
|
2000-07-05 |
2002-01-14 |
Capricorn Pharma, Inc |
Rapid-melt semi-solid compositions, methods of making same and methods of using same
|
US6375982B1
(en)
*
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
WO2002030392A2
(en)
|
2000-10-12 |
2002-04-18 |
Beecham Pharmaceuticals (Pte) Limited |
Formulation containing amoxicillin
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
US7157095B2
(en)
|
2000-10-13 |
2007-01-02 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release antifungal product, use and formulation thereof
|
US7105174B2
(en)
*
|
2000-10-13 |
2006-09-12 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-neoplastic product, use and formulation thereof
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US7074417B2
(en)
*
|
2000-10-13 |
2006-07-11 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-viral product, use and formulation thereof
|
GB0031267D0
(en)
*
|
2000-12-21 |
2001-01-31 |
Smithkline Beecham Plc |
Novel compositions
|
US20020197314A1
(en)
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
AU2002244295B2
(en)
*
|
2001-03-13 |
2006-02-09 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms containing glucocorticosteroid
|
EP1497148B2
(de)
*
|
2002-04-12 |
2011-10-05 |
Edscha Cabrio-Dachsysteme GmbH |
Verdeck für ein cabriolet-fahrzeug
|
US20040114368A1
(en)
*
|
2002-12-13 |
2004-06-17 |
Shyu Shing Jy |
Light device having rotatable or movable view
|
AU2004258953B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
EP1648418A4
(de)
|
2003-07-21 |
2011-11-16 |
Middlebrook Pharmaceuticals Inc |
Antibiotisches produkt, seine verwendung und formulierung
|
US8313776B2
(en)
|
2003-07-21 |
2012-11-20 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
EP1653925A1
(de)
|
2003-08-11 |
2006-05-10 |
Advancis Pharmaceutical Corporation |
Robustes pellet
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
WO2005027877A1
(en)
|
2003-09-15 |
2005-03-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
EP1663156A2
(de)
*
|
2003-09-19 |
2006-06-07 |
Penwest Pharmaceuticals Company |
Chronotherapeutische dosierformen
|
KR100782918B1
(ko)
*
|
2003-09-19 |
2007-12-07 |
펜웨스트 파머슈티칼즈 컴파니 |
지연 방출성 제형
|
EP1701705A4
(de)
*
|
2003-12-24 |
2007-08-08 |
Advancis Pharmaceutical Corp |
Verbesserte absorption von dosierformen mit modifizierter freisetzung
|
AP2006003704A0
(en)
*
|
2004-01-06 |
2006-08-31 |
Panacea Biotec Ltd |
Controlled release pharmaceutical composition comprising an acid insoluble polymer and a bioadhesivepolymer
|
WO2005099672A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Ranbaxy Laboratories Limited |
A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
|
FR2872044B1
(fr)
*
|
2004-06-28 |
2007-06-29 |
Flamel Technologies Sa |
Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
|
JP2008505124A
(ja)
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
パルス送達用錠剤
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
DE06769529T1
(de)
|
2006-01-27 |
2009-04-16 |
Schlumberger Holdings Ltd. |
Verfahren zur hydraulischen spaltenbildung einer unterirdischen formation
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US9120963B2
(en)
*
|
2006-11-08 |
2015-09-01 |
Schlumberger Technology Corporation |
Delayed water-swelling materials and methods of use
|
WO2009063916A1
(ja)
*
|
2007-11-16 |
2009-05-22 |
Asahi Kasei Chemicals Corporation |
水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
|
JP5101324B2
(ja)
*
|
2008-02-07 |
2012-12-19 |
日立建機株式会社 |
建設機械のNOx低減装置の配設構造
|
US8839865B2
(en)
*
|
2008-02-27 |
2014-09-23 |
Schlumberger Technology Corporation |
Slip-layer fluid placement
|
US9097077B2
(en)
*
|
2009-10-30 |
2015-08-04 |
Schlumberger Technology Corporation |
Downhole chemical delivery system and method
|
US8459353B2
(en)
|
2010-08-25 |
2013-06-11 |
Schlumberger Technology Corporation |
Delivery of particulate material below ground
|
US9234415B2
(en)
|
2010-08-25 |
2016-01-12 |
Schlumberger Technology Corporation |
Delivery of particulate material below ground
|
US8714248B2
(en)
|
2010-08-25 |
2014-05-06 |
Schlumberger Technology Corporation |
Method of gravel packing
|
US8448706B2
(en)
|
2010-08-25 |
2013-05-28 |
Schlumberger Technology Corporation |
Delivery of particulate material below ground
|
EP3007568A4
(de)
|
2013-06-13 |
2016-11-09 |
Griffith Laboratories |
Verwendung resistenter stärken in beschichtungszusammensetzungen
|
WO2017062997A1
(en)
|
2015-10-09 |
2017-04-13 |
Reckitt Benckiser Llc |
Pharmaceutical formulation
|
JP2019527214A
(ja)
|
2016-07-14 |
2019-09-26 |
アカオジェン インコーポレイテッド |
細菌感染症の処置における使用のためのセフチブテンとクラブラン酸の組み合わせ
|
WO2022181625A1
(en)
*
|
2021-02-23 |
2022-09-01 |
Otsuka Pharmaceutical Co., Ltd. |
Centanafadine pharmaceutical formulations, and methods of making and using same
|